Authors
Latest:
The Effects of “Long COVID” and How Pharmacists Can HelpOften referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
Latest:
The DIR Hangover One Year Later: How Have Pharmacists Fared?Nearly a year after the change to direct and indirect remuneration fees, pharmacy owners talk about how the ruling has impacted their lives.
Latest:
The Impact of COVID-19 on Pharmacy Management and CompliancePharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.
Latest:
Misdosing: More Common Than You ThinkUnfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.
Latest:
Examining the Interplay Between Guideline-Directed Medical Therapy and HyperkalemiaAn expert discusses the critical balance in heart failure GDMT between maximizing lifesaving treatments and managing hyperkalemia risk, highlighting how novel potassium binders and strategic medication choices enable safer continuation and optimization of therapy to improve patient outcomes.
Latest:
While Telemedicine Decreased After COVID-19 Peak, Mental Health Video Visits RoseCompared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.
Latest:
Patient-First Approach Addresses Unique Needs of Patients With Rare DisordersNow more than ever, 30 million Americans living with a range of 7000 rare or orphan diseases require a high level of therapy adherence support.
Latest:
How This Pharmacist Achieved Dreams of Becoming an Independent OwnerTaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, explored the pharmacy profession from her perspective as an independent owner.
Latest:
Overcoming Vaccine Hesitancy With PatientsPharmacists can work with their patients to address concerns about vaccinations.
Latest:
Belantamab mafodotin-blmf for Relapsed or Refractory Multiple MyelomaBelantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.
Latest:
COVID-19 Vaccine Recommendations Spark Confusion and Trust Concerns, Experts WarnLauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy.
Latest:
Prescribing Cascades Can Often Lead to Polypharmacy for Older AdultsPharmacists are essential in helping to identify patients at risk for inappropriate prescribing.
Latest:
The Potential Impact Pharmaceutical Tariffs May Have on PharmaciesMarta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Latest:
Pharmacy Law Lowdown: Getting to Know the Hosts, Mid-Year UpdatesThis episode introduces the hosts and explores key legal issues facing independent pharmacies, including PBM terminations and state board compliance.
Latest:
Thermometers: A ReviewPharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Latest:
Bempedoic Acid for HypercholesterolemiaAn expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Latest:
Q&A: Pharmacists Can Help Raise Awareness About CGMsHeather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Latest:
Practice Update: Treating Patients Hospitalized With COVID-19Several institutions have published guidance on how to treat patients hospitalized with COVID-19.
Latest:
Cell-Based Flu Vaccine May Be More Cost-Effective, Beneficial Among ChildrenA new study found that switching from a primary national plan of egg-based vaccines to cell-based vaccines for the flu would significantly reduce the impact of the seasonal virus at a lesser production and distribution cost.
Latest:
Expert Discusses Transparency and Education for the Current Measles OutbreakCrystal Hodge discusses being transparent about adverse effects of the MMR vaccine and educating patients about measles.
Latest:
Safeguarding Patient Health During Natural Disasters: Lessons from the Recent California WildfiresSpecialty pharmacies help support their continuity of care with practiced disaster response plans.
Latest:
How iA is at the Forefront of an Evolving Pharmacy LandscapeAlecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how they’ve impacted pharmacists and their businesses.
Latest:
PQA Evaluating Pharmacy Impact on Immunization Assessment and Gap ClosureThe pilot Will Evaluate Measure Concepts and Data Exchange in Value-Based Arrangements.
Latest:
Insurance Coverage is Lagging in a Golden Age of Obesity TreatmentAntiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.
Latest:
How the Complexities, Trends in Drug Benefit Design Are Evolving in Real TimeWith the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.
Latest:
OTC Analgesic Toxicity Common Among ChildrenAccording to poison control data, many children aged 0 to 17 experience toxicity from over-the-counter analgesics like ibuprofen and acetaminophen.
Latest:
Pharmacy Access and Its Impact on Medicare BeneficiariesPharmacy closures are reducing access to medications and services, raising concerns about their impact on patient care, especially for Medicare beneficiaries.
Latest:
New Drug Review: FDA Approves Lazertinib Combination Therapy for Non–Small Cell Lung CancerStudy results show improvement in progression-free survival at 22 months.
Latest:
The Effects of COVID-19 on Specialty Prescribing HabitsThe remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.
